Stephanie Bolton's most recent trade in LivaNova PLC was a trade of 15,385 Stock Appreciation Rights done . Disclosure was reported to the exchange on March 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| LivaNova PLC | Stephanie Bolton | President, Global Epilepsy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2025 | 15,385 | 15,385 | - | - | Stock Appreciation Rights | |
| LivaNova PLC | Stephanie Bolton | President, Global Epilepsy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2025 | 7,027 | 7,027 | - | - | Performance Stock Units | |
| LivaNova PLC | Stephanie Bolton | President, Global Epilepsy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2025 | 7,027 | 7,027 | - | - | Restricted Stock Units | |
| LivaNova PLC | Stephanie Bolton | President, Global Epilepsy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2025 | 6,024 | 15,586 (0%) | 0% | 0 | Ordinary Shares | |
| LivaNova PLC | Stephanie Bolton | President, Global Epilepsy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2025 | 3,513 | 3,513 | - | - | Performance Stock Units | |
| LivaNova PLC | Stephanie Bolton | President, Global Epilepsy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2025 | 3,513 | 3,513 | - | - | Performance Stock Units | |
| LivaNova PLC | Stephanie Bolton | President, Global Epilepsy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.13 per share. | 30 Mar 2025 | 2,835 | 12,751 (0%) | 0% | 39.1 | 110,934 | Ordinary Shares |
| LivaNova PLC | Stephanie Bolton | President, Global Epilepsy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2025 | 1,330 | 2,659 | - | - | Restricted Stock Units | |
| LivaNova PLC | Stephanie Bolton | President, Global Epilepsy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2025 | 1,229 | 3,686 | - | - | Restricted Stock Units | |
| LivaNova PLC | Stephanie Bolton | President, Global Epilepsy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2025 | 1,060 | 0 | - | - | Performance Stock Units | |
| LivaNova PLC | Stephanie Bolton | President, Global Epilepsy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2025 | 805 | 0 | - | - | Performance Stock Units | |
| LivaNova PLC | Stephanie Bolton | President, Global Epilepsy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2025 | 717 | 0 | - | - | Performance Stock Units | |
| LivaNova PLC | Stephanie Bolton | President, Global Epilepsy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2025 | 457 | 457 | - | - | Restricted Stock Units | |
| LivaNova PLC | Stephanie Bolton | President, Global Epilepsy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2025 | 426 | 0 | - | - | Restricted Stock Units | |
| LivaNova PLC | Stephanie Bolton | President, Global Epilepsy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2024 | 10,746 | 10,746 | - | - | Stock Appreciation Rights | |
| LivaNova PLC | Stephanie Bolton | President, Global Epilepsy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2024 | 7,744 | 13,205 (0%) | 0% | 0 | Ordinary Shares | |
| LivaNova PLC | Stephanie Bolton | President, Global Epilepsy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2024 | 4,915 | 4,915 | - | - | Performance Stock Units | |
| LivaNova PLC | Stephanie Bolton | President, Global Epilepsy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2024 | 4,915 | 4,915 | - | - | Restricted Stock Units | |
| LivaNova PLC | Stephanie Bolton | President, Global Epilepsy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.94 per share. | 30 Mar 2024 | 3,643 | 9,562 (0%) | 0% | 55.9 | 203,789 | Ordinary Shares |
| LivaNova PLC | Stephanie Bolton | President, Global Epilepsy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2024 | 2,457 | 2,457 | - | - | Performance Stock Units | |
| LivaNova PLC | Stephanie Bolton | President, Global Epilepsy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2024 | 2,457 | 2,457 | - | - | Performance Stock Units | |
| LivaNova PLC | Stephanie Bolton | President, Global Epilepsy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2024 | 1,961 | 0 | - | - | Performance Stock Units | |
| LivaNova PLC | Stephanie Bolton | President, Global Epilepsy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2024 | 1,706 | 0 | - | - | Performance Stock Units | |
| LivaNova PLC | Stephanie Bolton | President, Global Epilepsy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2024 | 1,330 | 3,989 | - | - | Restricted Stock Units | |
| LivaNova PLC | Stephanie Bolton | President, Global Epilepsy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2024 | 1,290 | 0 | - | - | Performance Stock Units | |
| LivaNova PLC | Stephanie Bolton | President, Global Epilepsy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2024 | 573 | 0 | - | - | Restricted Stock Units | |
| LivaNova PLC | Stephanie Bolton | President, Global Epilepsy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2024 | 457 | 914 | - | - | Restricted Stock Units | |
| LivaNova PLC | Stephanie Bolton | President, Global Epilepsy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2024 | 427 | 426 | - | - | Restricted Stock Units |